A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.
about
Cholangiocarcinoma: increasing burden of classificationsHepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studiesManagement of perihilar cholangiocarcinoma in the era of multimodal therapyEpidemiology, risk factors, and pathogenesis of cholangiocarcinomaRisk of hepatobiliary cancer after solid organ transplant in the United States.Cluster of liver cancer and immigration: a geographic analysis of incidence data for Ontario 1998-2002.Liver cancer mortality among male prison inmates in Texas, 1992-2003.Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea.Cholangiocarcinoma: lessons from ThailandOptimal biliary drainage for inoperable Klatskin's tumor based on Bismuth type.Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors.Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.Pathogenesis, diagnosis, and management of cholangiocarcinomaTemporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population.Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience.Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosisPossible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective studyUltrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: a population-based prospective study of 4,225 subjects in an endemic area.Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling ProjectLymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis.Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database.Corilagin suppresses cholangiocarcinoma progression through Notch signaling pathway in vitro and in vivo.Socioeconomic status and hepatocellular carcinoma in the United States.Hepatocellular carcinoma prevalence and mortality in a male state prison populationIncidence and risk factors for hepatocellular carcinoma after solid organ transplantation.Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States.Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinomaThe burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004.Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan.Resection of hepatocellular carcinoma in patients without cirrhosis.Targeted therapy for biliary tract cancers.Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.Ambient ultraviolet radiation exposure and hepatocellular carcinoma incidence in the United States.New concept: cellular senescence in pathophysiology of cholangiocarcinoma.Anti-cancer effect of N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2,3-dihydronaphtho[1,2-b]furan-2-carboxamide, a novel synthetic compound.KRAS Mutation as a Potential Prognostic Biomarker of Biliary Tract Cancers.The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
P2860
Q26991678-AAB29376-25F1-49DE-BA53-BB625C8792C3Q26998595-757A983F-B2EF-4C02-BC16-0C3EBBAE9F2EQ28273788-5571B4B5-6B5B-49D6-B813-15483225B573Q28293076-779DC20C-4F0E-4BB3-944E-A09C78EC1A3CQ30581052-7D112E0D-488E-4D2F-B81A-FFFCCDDC7162Q31157318-DF4957F4-AECF-4164-85D2-D4678701E9F6Q33889865-6A6DC431-7AFE-497C-8D4C-D6934B7AADC9Q33935272-6D204051-9B27-408A-B137-FA50A6CF60F0Q34034208-484324BA-750D-4935-9231-7289B8C5DD46Q34224870-77468662-32C4-42E1-B93E-8DFC321B3E3AQ34398255-7DD328A0-0EFE-42F7-A638-82C561108547Q34627921-688737F7-B83E-484F-8B89-073C1FBF7BDBQ34656747-2ACBEADA-7BA4-4FBD-A3C9-E5E4B9AC3083Q35096951-011D1CD8-EAE8-4B66-870A-0E5099C41729Q35099263-B70A207C-08C3-4509-AB3A-DC344E4F174DQ35131896-C6180AF1-D50E-45E5-B502-7B69934E0EDCQ35868937-D7CCBB23-FF8F-4B38-9EE4-46A58FC02D34Q35896512-9DC20E3E-BC3E-47E8-89D6-DC65EE5127C4Q36037403-F6790C34-C3FC-46FB-9B61-336F88C4DA7AQ36078583-84B8C932-85A5-465A-A5EA-FD352E035764Q36120982-647DE3B6-E7A9-4A5E-A02A-9415256EFB93Q36154934-F7E4F691-44EA-4928-97AC-C406D9F69A8CQ36376264-740B2D56-BC6D-45F1-AA67-8DE48026359CQ36570311-B8D5E8CF-AE5F-480A-9777-A4A698B2E462Q36734204-88C7296F-6AE8-46B7-8670-55EFD35369EBQ36826126-67C75DE6-B2BC-4C9A-8EA4-0ABAC71FFC61Q37015123-C84D7DD5-F82E-4C65-A698-5E66B90572EEQ37270948-5CBC13E0-9A03-46D3-9228-46331DD7BC4CQ37274308-BE4FE8B2-CC49-4F20-82D5-F91119F93280Q37351498-6A2E5E41-D019-4E29-8D74-0AE41AD87BB3Q37421369-24EB7404-55A4-4823-9627-A47301C3D1F9Q37725159-B5E8A12C-6350-4B79-84BF-63769BE098FFQ37833569-17B374B6-66B1-44CF-9D06-FA1D96245372Q37982650-AD6B97A4-5B49-4BF0-85A2-F78D9B6E2C7DQ38441297-033DBE17-7FDD-4DAD-BA44-A8FF773E0B22Q38640277-2FA3461D-6035-4346-AB51-CC5B8CCA26AAQ38672946-DFC6915C-D798-4730-9BCD-B792E03D7CA5Q38888371-660476B4-FD7A-4BEB-81D8-E397C310B109Q39070009-4556A6CD-1679-40BA-A99A-3C8D47A3AB3CQ39347890-4F1C04B6-9EB8-476F-80E5-FA42BFB87200
P2860
A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A comparison of trends in the ...... arcinoma in the United States.
@en
type
label
A comparison of trends in the ...... arcinoma in the United States.
@en
prefLabel
A comparison of trends in the ...... arcinoma in the United States.
@en
P2093
P1476
A comparison of trends in the ...... arcinoma in the United States.
@en
P2093
Hashem B El-Serag
Katherine A McGlynn
Robert E Tarone
P304
P356
10.1158/1055-9965.EPI-05-0811
P577
2006-06-01T00:00:00Z